Volume 16 | December 6, 2023

^‍

Reflecting on All We Have Accomplished Together

As we are wrapping our gifts for our dear ones and writing our cards, we are also wrapping up our year at MIB Agents with you, our dear ones, top of mind.  We have accomplished a lot together in 2023, and with your wholehearted participation, we are well on our way to "better" with and for the osteosarcoma community.  Here are some of those accomplishments:

- Hosted 19 fundraisers for osteosarcoma programs and research

- Funded $650,000 in osteosarcoma research grants

- Reviewed 21 patient cases in 7 tumor review boards

- Shared research from 28 researchers on OsteoBites

- Connected to our AYA community with 9 osTEAo podcasts

- Sent out 400+ Warrior Mail packages to 65 OsteoWarriors

- Created a community of 30+ bereaved parents in 39 sessions of Healing Hearts

- Connected 20 newly diagnosed families to Ambassador Agents

- Distributed nearly 400 copies of our Osteosarcoma Handbook

- Assembled 180+ in our community for our annual FACTOR conference.

Together, our patient, scientific, and industry communities made all of this possible with their time, passion, expertise, and financial contributions.

Amidst this momentum to Make It Better, we never lose sight of our Because Ofs, who continue to inspire, contribute in many ways, and fuel more momentum and determination to Make It Better.

From our MIB Agents family to yours, we wish you a happy and healing holiday, with much optimism for the new year.

‍
With hope,

Ann

Save The Date

^{Our Community}‍

Shop Holiday Gifts for OsteoWarriors

Find the perfect holiday gift or stocking stuffer for your OsteoWarrior!  

From cozy socks to teddy bears, and mugs perfect for hot cocoa, you can find the perfect gift to bring comfort and Make It Better!

Shop the MIB Boutique

Get the latest on MIB Agents!

‍

Don't miss a thing and stay up to date on MIB Agents with text updates!  Do messages get buried in your email inbox? You can now opt-in to receive text messages to get the latest on MIB Agents news and events. Texts will only be used for MIB Agents communication and we will never sell your information or share with other organizations.

‍

Opt-In for Text Messages

‍

‍

‍

‍

Meet the FOSTER Consortium

A European consortium that includes researchers, clinicians, patients and patient advocates, the FOSTER (Fight Osteosarcoma Through European Research) Consortium had its inaugural meeting in October 2022 in Paris, with a second meeting this past October in Bologna.  With nearly 300 members from across 20 countries, and 8 work packages from biology to late-effects, FOSTER aims to improve outcome of patients with osteosarcoma, in terms of duration and quality of life of survivors.

Read More About FOSTER

Career Connections‍

1. D4CG Project Manager
2. Senior Research Technician - Majzner Pediatrics Lab
3. Sarcoma Faculty Clinician/Translational Researcher/Physician Scientist at OHSU
4. Postdoctoral and staff scientists in the Curtis Lab at Stanford Medicine
5. Behavioral Health Staff Scientist in the Psychosocial Support and Research Program, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health (NIH)

If you have a job posting and you would like it included here, please email christina@mibagents.org.

^‍

^EDUCATION‍

^{OsteoBites Webinar Series}

Watch Past Episodes and See the Upcoming Schedule

‍

^{Join the New Osteosarcoma Google Group}

The MIB Agents Osteosarcoma Medical Discussion Network (OSMDNet) is a closed Google Group for global clinicians and researchers interested in osteosarcoma. With the goal of fostering global collaboration in the scientific community, the discussion group is a forum to exchange professional insights, experiences, and information related to osteosarcoma.  OSMDNet is a private discussion group managed by MIB Agents and information shared on this discussion group is intended for educational purposes only.  Any practicing PA, NP, DO, MD and/or PhD at an accredited institution anywhere in the world with a clinical or research interest in osteosarcoma can request to join.

Request to Join OSMDNet

‍

^{Tumor Review Board for Osteosarcoma}

A virtual tumor review board for osteosarcoma, TURBO is open to global clinicians or researchers with an interest in osteosarcoma.  Patients and families are welcome to ask their oncologists to present a case on their behalf.  Join TURBO to request an invite or submit a case.
‍

Next meeting: January 10th at 5pm ET

‍Join TURBO

Osteosarcoma in the News

• Researchers create machine learning model to calculate chemotherapy success in patients with osteosarcoma
  

• Immunosuppressive tumor microenvironment of osteosarcoma
  

• Osteosarcomas with few chromosomal alterations and/or affecting adults are genetically heterogeneous
  

• Trial launched to test CAR T-cell therapy in dogs diagnosed with solid tumors
  

• Intrinsic epigenetic state of primary osteosarcoma drives metastasis
  

• Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy
  

• Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma
  

• New Study Aims to Revolutionize Osteosarcoma Treatment for Giant Dog Breeds

‍

PROGRAMS

Osteosarcoma Manual en Español

Escrito por OsteoParents y revisada por expertos, Osteosarcoma de Nuestras Familias a la Suya es un recurso imprescindible para familias recientemente diagnosticadas. El manual proporciona una descripción general de qué esperar desde la perspectiva de las familias con osteosarcoma que han recorrido este camino, con una descripción general del tratamiento y el vocabulario médico. Descargue una copia en PDF gratuita o solicite una impresión gratuita que incluye recursos adicionales de nuestros colaboradores.

‍

PDF gratuitas

Copias impresas

‍‍

RESEARCH

OutSmarting Osteosarcoma Applications Due January 26th

The OutSmarting Osteosarcoma 2024 research grant application is now open on Proposal Central! Applications are due January 26, 2024, with notification in May 2024. Awards include a $100,000 one year grant and a $50,000 Young Investigator one year grant.  

Watch a 13 minute video on the OutSmarting application and review process

Lear More About Past Recipients

Read the Program Guidelines

Learn More About our YI Grant Review Program

‍

Apply for a Research Grant by Jan 26

‍

FACTOR Abstracts Due Jan 12th

‍

Have a compelling topic to share with the osteosarcoma community?

We want to hear about it! MIB Agents is now accepting abstract submissions for oral presentations at FACTOR 2024. Abstracts can be submitted online at Proposal Central until January 12, 2024.

‍

Watch our FACTOR 2023 Highlights to see the magic of our annual osteosarcoma conference. You will come to collaborate and leave inspired. Watch all FACTOR 2023 panels on our YouTube channel.

Submit an Abstract by Jan 12

‍

‍

Osteosarcoma Research Funding Opportunities

‍

MIB Agents believes in the value of investing in research to Make It Better. Aside from our OutSmarting Osteosarcoma grant, we want to facilitate osteosarcoma research from any funding mechanism. Check out our list of Funding Opportunities for osteosarcoma research with deadlines and contact info.  Here's to more funded osteosarcoma research in 2024!

Find Funding Opportunities

‍

‍

If you have a trial that is currently enrolling osteosarcoma patients, please email christina@mibagents.org.

‍

All MIB Agents programs are free of charge, thanks to our generous donors like you who Make it Better.

Please consider a donation to support osteosarcoma patient programs, education, and research.

                  Donate                           

‍